- Home
- GOSS vs NMAD Comparison
GOSS vs NMAD Comparison
Compare GOSS & NMAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.18
N/A
Current Price
$3.94
Company Overview
Basic Information| Metric | GOSS | NMAD |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.5M | 112.7M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GOSS | NMAD |
|---|---|---|
| Price | $0.18 | $3.94 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $4.19 | N/A |
| AVG Volume (30 Days) | ★ 31.6M | 392.0K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.75 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,471,000.00 | $200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $201.64 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.11 | $3.12 |
| 52 Week High | $3.87 | $6.28 |
Technical Indicators
Market Signals| Indicator | GOSS | NMAD |
|---|---|---|
| Relative Strength Index (RSI) | 50.35 | 38.75 |
| Support Level | $0.13 | $3.96 |
| Resistance Level | $0.19 | $4.93 |
| Average True Range (ATR) | 0.02 | 0.51 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 32.40 | 45.32 |
Price Performance
Historical Comparison GOSS
NMAD
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).